Prosecution Insights
Last updated: April 19, 2026

Examiner: PHAN, DOAN THI-THUC

Tech Center 1600 • Art Units: 1613

This examiner grants 43% of resolved cases

Performance Statistics

43.1%
Allow Rate
-16.9% vs TC avg
728
Total Applications
+49.8%
Interview Lift
1221
Avg Prosecution Days
Based on 631 resolved cases, 2023–2026

Rejection Statute Breakdown

0.9%
§101 Eligibility
11.6%
§102 Novelty
46.2%
§103 Obviousness
23.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19337639 METHOD FOR PRODUCING A LIQUID COMPOSITION INCLUDING A NANOPARTICLE, AND FORMULATION THEREOF Non-Final OA GLOBAL LIFE SCIENCES SOLUTIONS UK LIMITED
17766445 OCULAR SEALANTS AND METHODS OF USING THE SAME Non-Final OA The Regents of the University of California
17018413 ANTITUMOR AGENT, ANTITUMOR EFFECT ENHANCER, AND ANTITUMOR KIT Final Rejection FUJIFILM Corporation
17924776 Methods and Compositions For Reducing Intraocular Pressure Final Rejection Georgia Tech Research Corporation
18680005 DELIVERY OF SURFACTANT SOLUBLE AGENT Non-Final OA The Procter & Gamble Company
18624704 ORAL PRODUCTS Non-Final OA NICOVENTURES TRADING LIMITED
17835000 ORAL COMPOSITION WITH NANOCRYSTALLINE CELLULOSE Final Rejection NICOVENTURES TRADING LIMITED
17482985 METHODS FOR TREATING DILATED CARDIOMYOPATHY Final Rejection Mars, Incorporated
17395116 ANTIMICROBIAL SHAPE MEMORY POLYMERS Final Rejection THE TEXAS A&M UNIVERSITY SYSTEM
18581955 CONTROLLED-RELEASE NICOTINE CHEWING GUM Final Rejection Altria Client Services LLC
17223800 CONTROLLED-RELEASE NICOTINE CHEWING GUM Final Rejection Altria Client Services LLC
17993555 BIOPOLYMER-ENCAPSULATED GLYCOSYLTRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS Final Rejection The Johns Hopkins University
16603359 PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT Non-Final OA SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
17789104 SILICA MICROCAPSULES Non-Final OA KAO CORPORATION
17614743 COMPOSITION FOR FORMING COATING FILM AND ULTRAFINE SHORT FIBER Final Rejection KAO CORPORATION
17600858 HAIR COSMETIC Final Rejection KAO CORPORATION
17323659 IN SITU GELLING POLYSACCHARIDE-BASED NANOPARTICLE HYDROGEL COMPOSITIONS, AND METHODS OF USE THEREOF Final Rejection McMaster University
18533542 THIN-SHELL POLYMERIC NANOPARTICLES AND USES THEREOF Final Rejection Academia Sinica
17943103 Solid Cleansing Compositions and Methods for the Same Final Rejection Colgate-Palmolive Company
18000678 FRAGRANCE COMPOSITION COMPRISING A FRAGRANCE COMPONET AND A NON-ODOROUS FRAGRANCE MODULATOR Final Rejection Coty Inc.
17611705 ISOTROPIC LIQUID CLEANSERS COMPRISING ACYL ISETHIONATE AND METHYL ACYL TAURATE SURFACTANT MIXTURES Non-Final OA Conopco, Inc., d/b/a UNILEVER
17423669 Covered Stent For Local Drug Delivery Final Rejection BIOTRONIK AG
18554018 DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS Non-Final OA Encapsys, LLC
18475472 Delivery Particles Based On Amine-Thiol-Ene Conjugates and Derivatives Non-Final OA Encapsys, LLC
18462537 DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS Non-Final OA Encapsys, LLC
17529554 Poly Acrylate and Poly(Beta-Amino Ester) Capsules with Enhanced Degradability Non-Final OA Encapsys,LLC
17263791 JANUS PARTICLE PREPARATION THROUGH TWO-PHASE INTERFACE ASSEMBLY Non-Final OA Johnson & Johnson Consumer Inc.
18727538 HIGH-TEMPERATURE-RESISTANT FRAGRANCE BEAD AND PREPARATION METHOD THEREFOR Non-Final OA FOSHAN MAGIC CRYSTAL TECHNOLOGY DEVELOPMENT CO., LTD.
17420507 NANOPARTICLES AND PREPARATION METHOD Non-Final OA Université Paris-Saclay
18034617 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS Final Rejection Givaudan SA

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month